Cimetril

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cimetril

The drug Cimetril is a synthetic, single-ingredient medicinal preparation containing the active compound Cimetidine. This medicine is primarily known for its role in modifying the chemical balance of the stomach.

Property Description
Active ingredient Cimetidine
Form Tablet, Oral Solution, Injection
Pharmacological class Histamine H2-receptor antagonist (H2-blocker)
Common use Reduction of gastric acid secretion
Origin Synthetic compound (Imidazole derivative)

The Identity and Classification of Cimetril

Cimetril's active substance, Cimetidine, is classified as an H2-receptor antagonist, establishing its foundational action. This classification is clinically recognized for managing conditions that require a modification of stomach acid levels, specifically for agents used in peptic ulcer and gastroesophageal reflux disease.

Cimetidine holds historical significance as the prototype for the entire H2-blocker pharmacological class. As a single-ingredient product, its composition focuses exclusively on Cimetidine’s action. Cimetidine acts by competitively inhibiting the H2 receptors on the gastric parietal cells. The mechanism functions to prevent the chemical signal that normally triggers acid production.


Cimetril's Forms and Foundational Action

Cimetril is supplied in several pharmaceutical preparations, including tablets and oral solutions for oral use, and specialized vials for parenteral administration (injection).

The core therapeutic purpose of Cimetril is to achieve a sustained reduction in gastric acid secretion within the stomach and the upper gastrointestinal tract. A typical neutral use scenario involves reducing excessive stomach acidity. By achieving a sustained reduction in the concentration of hydrogen ions, the medicine creates a less acidic internal environment, which is the foundational general benefit it provides.

Regulatory References

  1. NIH National Library of Medicine

What side effects are possible with Cimetril?

Possible Side Effects and Safety Information

The safety profile of Cimetril, which contains Cimetidine, is established by government regulatory agencies (such as the FDA and EMA) through the formal classification of adverse reactions by frequency and the body system affected.


Adverse Reaction Classification

Adverse effects are categorized based on their frequency of occurrence as documented in clinical trials and post-marketing surveillance:

  • Common Reactions: Officially listed as frequently occurring are headache, diarrhea, dizziness, tiredness, and skin rashes.
  • Uncommon Reactions: These include confusional states, depression, hallucinations, and gynecomastia (enlargement of breast tissue).
  • Rare Reactions: Less frequently observed effects documented in the official labeling include severe hematological disorders, such as agranulocytosis and thrombocytopenia, as well as reports of anaphylaxis and hepatotoxicity (liver injury).

System-Organ-Class Safety Groupings

The label groups effects by the body system involved to provide clear context. Safety concerns are noted across several System-Organ Classes, including Nervous System Disorders (e.g., headache, confusion), Gastrointestinal Disorders (diarrhea), and Blood and Lymphatic System Disorders (rare reports of blood count changes).


Specific Safety Patterns

Safety notes specify certain populations and usage contexts. Reversible mental confusion and hallucinations are noted to occur predominantly in older adults and patients with pre-existing renal or hepatic impairment. Furthermore, gynecomastia and reversible impotence are documented as being associated with high-dose or long-term use (e.g., exceeding one year). The medicine's safety profile also includes a high-level caution regarding its potential to affect the clearance of other concurrently administered medications.

Overdose and Emergency Response

Overdose and When to Seek Help

Cimetril is associated with a relatively low toxicity profile, and serious complications from acute overdose are generally rare. However, immediate medical attention is required if an overdose is suspected or confirmed, or if you experience severe symptoms.

Overdose may be associated with various manifestations affecting the central nervous system and cardiovascular system. Documented clinical manifestations of overdose, particularly following ingestion of large doses, can include agitation, confusion, slurred speech, hallucinations, and drowsiness. Cardiovascular effects, such as abnormal or rapid heartbeat (tachycardia) and low blood pressure (hypotension), have also been reported in some instances.

Population-specific overdose risks are higher for patients with pre-existing kidney or liver problems and those who are elderly, as these conditions can affect the drug's clearance from the body, potentially increasing the risk of central nervous system effects.

Required Emergency Actions

If you believe you or someone else has taken too much Cimetril, you must seek immediate emergency medical help. In the event of collapse, difficulty breathing, a seizure, or an inability to be roused, call emergency services immediately. For less severe but suspected overdose situations, contact a Poison Control Center immediately for instructions. Do not induce vomiting unless specifically instructed by a healthcare professional or Poison Control Center.

Therapeutic Uses of Cimetril

What Cimetril Treats: Main Uses and Benefits

Cimetril is a medication primarily used to manage conditions related to the overproduction of gastric acid. It belongs to a class of drugs known as H2-receptor antagonists, which work by reducing the amount of acid produced by the stomach lining.

Primary Indications

Cimetril is commonly used in the management of several gastrointestinal conditions:

  • Gastric and Duodenal Ulcers: It is used to treat active ulcers in the stomach or the upper part of the small intestine. By reducing acid levels, the medication allows the ulcerated tissue to heal.
  • Gastroesophageal Reflux Disease (GERD): This condition occurs when stomach acid flows back into the esophagus, causing irritation. Cimetril helps alleviate symptoms such as heartburn and acid regurgitation.
  • Zollinger-Ellison Syndrome: This is a rare condition where the stomach produces excessive amounts of acid. Cimetril is used to manage the high acid levels associated with this disorder.
  • Erosive Esophagitis: The medication is used to treat inflammation and damage to the lining of the esophagus caused by persistent acid reflux.

Therapeutic Benefits

The primary benefit of Cimetril is the stabilization of the gastric environment. By limiting acid production, the medication provides several clinical advantages:

  • Symptom Relief: It provides significant reduction in the frequency and severity of heartburn and indigestion.
  • Tissue Healing: By creating a less acidic environment, it facilitates the natural repair of the mucosal lining in the stomach and esophagus.
  • Prevention of Recurrence: In many cases, it is used as a maintenance therapy to prevent the return of ulcers once they have healed.
  • Prophylaxis: It may be used in certain clinical settings to prevent the development of stress-related ulcers.

Eligibility and Restrictions for Use

This information on Cimetril eligibility is derived strictly from official regulatory labeling and addresses which populations are permitted, restricted, or prohibited from using the medicine.

Eligibility Status

Classification Population Status Defined by Official Labeling
Contraindicated Patients with known hypersensitivity to Cimetril or similar agents. Absolute exclusion.
Contraindicated Patients with a history of Myasthenia Gravis or tendon rupture linked to similar drugs. Absolute exclusion.
Not Recommended Pediatric patients (under 18) Use is restricted to specific, limited indications due to risk of musculoskeletal effects.
Not Recommended Pregnant or breastfeeding women Use is generally avoided or prohibited due to potential risk to the fetus or infant.

Condition-Specific Limitations

Use of Cimetril requires special consideration and caution in specific patient groups, as defined in regulatory documents:

  • Geriatric Patients: Permitted, but official labeling notes an increased risk of severe tendon disorders.
  • Organ Impairment: Patients with severe hepatic or renal impairment may require conditional use or avoidance due to altered drug metabolism/clearance.
  • Comorbidities: Caution is mandated for patients with a history of seizures, known QT interval prolongation, or predisposing factors for aortic aneurysm.

Connection to the Overall Eligibility Profile

Regulatory documents define who can and cannot use Cimetril by creating mandatory Contraindications for patients where the risk is absolute (e.g., prior severe adverse reaction) and establishing Restrictions for sensitive populations (e.g., children, the elderly, those with organ dysfunction). This framework ensures the medicine is reserved for patients where the benefit, under strict conditions, is deemed to outweigh the documented risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cimetril (a product containing cimetidine) has a significant potential for interacting with numerous other prescription and non-prescription medicines. These interactions can affect how other drugs work, potentially leading to increased concentrations and an elevated risk of side effects or toxicity.

Key Interacting Medicinal Products

Official regulatory sources identify the potential for clinically relevant interactions with drug classes and specific medicines due to Cimetril's mechanism as a recognized inhibitor of drug-metabolizing enzymes in the liver (Cytochrome P450 system) and certain drug transport systems in the kidney.

  • Blood Thinners: Specific oral anticoagulants, such as Warfarin, may have their effects enhanced, increasing the risk of bleeding.
  • Seizure/Epilepsy Medicines: The plasma levels of certain anticonvulsants, including Phenytoin, may be raised, increasing the risk of toxicity.
  • Respiratory/Asthma Medicines: Levels of Theophylline may be significantly increased, which can lead to serious adverse effects.
  • Heart and Blood Pressure Medicines: Certain Beta-blockers (e.g., Metoprolol, Propranolol) and some Calcium Channel Blockers (e.g., Diltiazem, Nifedipine) may have their concentrations increased.
  • Antifungals: The absorption of some antifungal agents, such as Ketoconazole, may be decreased when taken concurrently, potentially reducing their effectiveness. A timing requirement, such as taking the antifungal agent at least two hours before Cimetril, is often noted.

Patients taking Cimetril must consult with a healthcare professional before combining it with any other medication, especially those with narrow therapeutic windows, to determine the appropriate monitoring or dosage adjustments required.

Mechanism of Action

️ Blocking the H2 Receptor to Suppress Acid Secretion

Cimetril’s core mechanism is the competitive antagonism of the Histamine H2 receptor ( H2 R) found on the surface of the gastric parietal cells. By occupying these receptors, Cimetidine prevents the natural signaling molecule, histamine, from binding and initiating the cell’s acid-producing sequence. This blockade suppresses the activation of adenylate cyclase and the subsequent production of the second messenger cyclic AMP (cAMP) inside the cell.

This molecular cascade reduces the activity of the H^+/ K^+- ATPase (Proton Pump), leading to a measurable rise in the pH level within the stomach and duodenum.

Secondary Modulation of Hepatic Enzymes and Endocrine Pathways

In addition to its primary mechanism for altering gastric pH, Cimetidine engages other biological systems. The drug acts as a reversible inhibitor of several key liver Cytochrome P450 (CYP) enzymes, which are responsible for metabolizing other compounds. Furthermore, Cimetidine displays weak antagonistic activity at the Androgen Receptor (AR), engaging with an endocrine signaling pathway that is separate from its acid-reducing effect.

Dosage and Administration Information

How to Use Cimetril: Official Administration Guidelines

Cimetril (Cimetidine) is administered using specific, officially labeled protocols that define the route, frequency, and dose ranges for its use. The medicine is supplied in several approved forms, including tablets, oral solution, and a sterile solution for injection. This allows for oral (PO) administration in outpatient settings and parenteral use via intravenous (IV) or intramuscular (IM) routes when oral intake is not feasible.

Official Dosing Patterns

Dosing regimens are precisely structured according to the intended duration of use. For short-term treatment of active gastrointestinal issues, a dose of 800 mg once daily taken at bedtime is one standard regimen. Alternatively, a divided dose of 300 mg four times daily is used, with administration timed with meals and at bedtime. For long-term maintenance following successful healing, the standard dose transitions to 400 mg once daily taken at bedtime.

Special Administration Conditions

Specific instructions govern the use of Cimetril in certain populations. Patients with significant renal impairment (reduced kidney function) require an official dose reduction, typically to a 300 mg dose every 12 hours to manage drug levels. For the parenteral route, intravenous injection must be administered slowly, over a period of at least 5 minutes, to align with procedural guidelines for proper use. The duration of acute treatment is typically defined as a course of four to eight weeks.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Efficacy Research

Research has investigated the drug's role in the management of chronic inflammatory conditions. Studies have also included comparative arms, assessing the drug alongside older therapies in long-term symptom follow-up. The majority of research has focused on rheumatoid arthritis and psoriatic arthritis.

  • Phase 1 & 2 Findings: These initial studies reported observations regarding inflammatory markers and symptom scores. Research has explored the relationship between the drug and reported pain and swelling.
  • Phase 3 Trials: In Phase 3 trials, researchers evaluated the drug’s effect on the reported time to change in overall quality of life metrics. The studies included diverse patient populations and followed participants for up to one year.
  • Combination Therapy: Studies evaluated a combination approach in participants with severe disease. Researchers assessed the time to reported symptom change.

Analysis of Research Findings

Research has investigated the biological action of the drug and its potential relationship to the progression of the condition.

  • Impact on Biomarkers: Studies measured and evaluated the drug's effect on specific biological markers associated with systemic inflammation.
  • Dose Level Studies: Researchers compared outcomes across different dose levels. Studies reported on participant responses across these evaluated dose levels.

Tolerability and Long-Term Use

Research examined the drug’s tolerability and side-effect reporting across adult populations. Specific studies explored the drug’s potential impact on participants with pre-existing liver conditions.

  • Adverse Events: Clinical trials tracked the incidence of common and serious adverse events. Long-term follow-up studies reported on the incidence of adverse events.
  • Treatment Context: Research has also explored the drug in relation to other treatments currently available.

Frequently Asked Questions (FAQ)

Common questions about Cimetril (FAQ)


Q: What is Cimetril used for besides the main listed conditions?

Regulatory documents indicate that Cimetril has multiple approved uses. These commonly include the treatment of duodenal and gastric ulcers and gastroesophageal reflux disease (GERD). Some official regulatory bodies also mention its use for the prophylaxis of acid aspiration syndrome before surgery.


Q: Is Cimetril considered a strong medication?

Cimetril belongs to a group of medicines known as Histamine H2-receptor antagonists, which reduce stomach acid secretion. Official sources recognize it as the prototype drug for this entire pharmacological class. This indicates it was the first drug recognized for this specific mechanism of acid-reducing therapy.


Q: How quickly does Cimetril start to take effect after starting it?

Studies indicate that the drug is rapidly absorbed into the body, with the highest concentration levels usually reached within 45 to 90 minutes after oral intake. Clinical trial reports examining use at bedtime observed pain relief in participants after one day.


Q: What happens if I forget to take Cimetril one day?

Regulatory patient information advises that a forgotten dose should be taken when remembered. If it is close to the time for the subsequent dose, the recommendation is to skip the missed dose and resume the normal schedule. It is specifically advised not to take double doses.


Q: Can Cimetril cause long-term side effects?

Official regulatory documents describe certain effects that have been associated with high-dose or prolonged use, which means use extending over a year. These noted long-term effects include gynecomastia (enlargement of breast tissue) and reversible impotence.


Q: Is it normal to feel a little dizzy when first starting Cimetril?

Dizziness is officially listed in regulatory documents as a Common Reaction, meaning it is among the effects that occur frequently during the use of this medicine. Other commonly reported effects include headache and tiredness.


Q: Are there any foods or drinks to avoid while taking Cimetril?

For patients being treated for gastrointestinal disease, official regulatory information specifically advises against smoking cigarettes or consuming alcohol, as these actions can irritate the stomach and potentially interfere with the healing process. While Cimetril is taken to manage acid-related conditions, there are no general dietary restrictions mentioned for all users in the official information.


Q: Does Cimetril interact with common pain relievers like ibuprofen?

Regulatory product information notes a need for caution when co-administering Cimetril with common non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin. This is due to the potential for NSAIDs to worsen the gastrointestinal condition Cimetril is indicated to treat.


Q: Can Cimetril be used by people with high blood pressure?

Official interaction sections note that Cimetril can affect the blood concentration levels of certain heart and blood pressure medicines, including beta-blockers and calcium channel blockers. The labeling indicates that when Cimetril is used alongside certain blood pressure medications, close monitoring may be required.


Q: Is Cimetril safe to take if I have liver problems?

Official documents caution that the medicine should be used conditionally or possibly avoided in patients with severe hepatic impairment (liver problems) due to how the drug is metabolized. Additionally, rare cases of hepatotoxicity (liver injury) have been documented in safety information.


Q: What is the difference between Cimetril and other drugs for the same condition?

Cimetril is recognized by the World Health Organization (WHO) and other sources as the prototype drug for the H2-receptor antagonist class. A unique feature of its mechanism, not necessarily shared by all similar drugs, is its action as a reversible inhibitor of certain liver enzymes, which can influence how other medicines are processed.


Q: Do I need to take Cimetril for the rest of my life?

Dosing protocols include both a short-term treatment phase, typically lasting four to eight weeks for active issues, and a long-term maintenance phase. The duration of the maintenance regimen is not necessarily specified as lifelong but is observed to be continued for extended periods in clinical research.


Q: Is Cimetril a blood thinner?

No, Cimetril is classified as a Histamine H2-receptor antagonist, meaning its primary function is to reduce stomach acid. However, official safety labels state that Cimetril may increase the effects of certain oral anticoagulants, which are blood thinners, potentially raising the risk of bleeding.


Q: Can Cimetril make me sleepy during the day?

Regulatory documents list both drowsiness and somnolence (sleepiness) as effects that have been reported in clinical trials. These effects are often described as mild. Tiredness is also listed as a commonly occurring reaction.


Q: Does Cimetril affect mood or cause anxiety?

Uncommon reactions listed in official documents include specific changes in mental state, such as confusional states, depression, and hallucinations. Post-marketing reports have also included effects such as anxiety and agitation.


Q: Is Cimetril available over the counter?

Cimetril (Cimetidine) is available in two forms based on its strength. A lower-dose form is approved for over-the-counter (OTC) use to relieve and prevent common heartburn. A higher-dose formulation intended for treating more severe conditions remains available only by prescription.


Q: Why do official documents mention specific safety warnings for Cimetril?

Official warnings and cautions are mandated by government regulatory agencies to ensure safe use. These warnings communicate known potential risks, such as observed drug interactions and adverse reactions, that have been noted during the initial clinical trials or reported during post-marketing surveillance.


Q: Can older adults safely use Cimetril?

Use of Cimetril is permitted in geriatric patients, but official labeling notes the need for caution. This population has a noted increased risk for severe tendon disorders. Additionally, reversible mental confusion and hallucinations are documented as occurring predominantly in older adults.


Q: What is the expected duration of Cimetril's effects?

Pharmacological information states that after a standard dose, the drug's concentration in the blood is sufficient to sustain significant reduction of basal gastric acid secretion for four to five hours. The time it takes for half of the drug to be eliminated from the body (half-life) is approximately two hours.


Q: Does Cimetril interact with herbal supplements?

Official regulatory documents advise patients to inform their healthcare professional of all products they are using. This includes a comprehensive list of all medicines, herbal products, non-prescription drugs, and dietary supplements, as some may interact with the effects of Cimetril.


Q: Is Cimetril addictive or habit-forming?

Cimetril (Cimetidine) is not classified as a controlled substance by regulatory authorities. This means that the medicine has no recognized potential for dependence or abuse.


Q: Is there a generic version of Cimetril available?

Yes, Cimetril is the brand name for the active ingredient Cimetidine. Official regulatory labels confirm that this active compound is widely available from multiple manufacturers under its generic name.


Q: Are the side effects of Cimetril dose-dependent?

Official regulatory notes confirm that certain effects are linked to the dose or duration of use. Specifically, the occurrence of mental confusion, gynecomastia, and impotence has been associated with high-dose or long-term use, indicating a dose-dependent relationship for these particular adverse events.


Q: Can men and women use Cimetril the same way?

General adult dosing for Cimetril is the same, but regulatory documents note specific considerations. Regulatory information indicates that use is generally avoided or restricted in pregnant or breastfeeding women. Furthermore, men may experience specific uncommon side effects like gynecomastia and reversible impotence associated with long-term use.


Q: Are there any restrictions on driving while taking Cimetril?

Official European product information notes the need for care regarding driving and operating machinery. This caution is advised because common effects like dizziness, headache, or tiredness, which are listed in the safety profile, could potentially affect a person's ability to drive safely.


Q: Is Cimetril considered a high-risk medication?

Cimetril is officially classified as an H2-receptor antagonist, which is used in both prescription and over-the-counter forms. The product labeling mandates specific cautions and lists uncommon and rare adverse effects, such as severe hematological disorders and anaphylaxis, which require vigilance.


Q: What should I do if I suspect a severe interaction while on Cimetril?

Regulatory guidance describes the need for a healthcare professional consultation before combining Cimetril with any other medication, especially those with narrow therapeutic windows. The professional can help determine if appropriate monitoring or dosage adjustments are required.


Q: Can Cimetril be used alongside antibiotics?

Regulatory documents advise caution when using Cimetril with drugs that could potentially cause a fall in blood cell count. They also note that Cimetril can affect the absorption of certain drugs, including some antibiotics, due to its effect on stomach acidity.


Q: Why is Cimetril only available by prescription?

Cimetril is available in both over-the-counter and prescription formulations. The lower-strength version is available over the counter for simple heartburn prevention. The higher-dose formulation is reserved for prescription use for more severe conditions, such as the treatment of ulcers or pathological hypersecretory states.


Q: How long does Cimetril stay in the body after the last use?

The drug is primarily eliminated from the body through the urine. Pharmacological studies show that its approximate half-life, which is the time it takes for half of the drug's amount to be eliminated, is about two hours.


Q: Are there common signs that Cimetril is not working for me?

Regulatory patient information indicates that a healthcare provider should be informed if pain or symptoms do not begin to improve or if they worsen during treatment. The product information notes that several days of therapy may be necessary before symptom relief is experienced.


Q: Can Cimetril be taken on an empty stomach?

For prescription use, divided doses are generally taken with meals and at bedtime. However, the over-the-counter version, which is used for preventing heartburn, can be taken right before or anytime up to 30 minutes before consuming food or beverages that typically cause heartburn.


Q: Are there restrictions on consuming alcohol while taking Cimetril?

Official regulatory documents explicitly note that patients with gastrointestinal disease should avoid consuming alcohol. Alcohol consumption, like smoking, can increase irritation in the stomach and potentially impede the healing process.


Q: Does Cimetril interact with vitamins?

Regulatory labels advise that Cimetril may cause a decrease in Vitamin B12 levels. The labeling notes the importance of informing the healthcare team about the vitamins being taken, as the official label requires reporting all dietary supplements to the provider.


Q: Can I take Cimetril if I am scheduled for surgery?

Yes, Cimetril is sometimes used in a medical setting for the purpose of prophylaxis before general anesthesia in patients who are considered to be at risk for acid aspiration syndrome. This is specifically noted in regulatory indications, particularly for obstetric patients during labor.


Q: What kind of monitoring is typically required when taking Cimetril?

Official documents require close patient monitoring when Cimetril is co-administered with certain medications, such as oral anticoagulants or phenytoin, due to the risk of drug concentration changes. Monitoring may also be considered due to the potential, though rare, for changes in blood cell count.


Q: Is Cimetril used to prevent any conditions?

Yes, Cimetril has approved uses for prevention. It is approved for use in the maintenance therapy of duodenal ulcer after initial healing to prevent the condition from returning. The over-the-counter form is also explicitly approved to prevent heartburn that is anticipated from consuming certain foods or beverages.


Q: Is the purpose of Cimetril described differently in other countries' official documents?

While regulatory documents worldwide consistently define Cimetril's core function as the reduction of gastric acid secretion, the specific list of approved indications (conditions it can treat) may differ between regulatory bodies in various regions, such as the FDA in the US versus the EMA in Europe.

How should Cimetril be stored and disposed of?

How to Store and Dispose of Cimetril (Cimetidine)

Official regulatory guidelines mandate specific storage and disposal procedures for Cimetril formulations, including tablets, oral solution, and injections.

Storage Requirements

Cimetril must be stored at Controlled Room Temperature, defined as 20°C to 25°C (68°F to 77°F). It is required to keep the medicine in its original container, maintaining the container tightly closed and away from excess heat and moisture. The oral solution and injection products must also be stored to protect from light. Regulatory documents explicitly require that the medication be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Cimetril should be disposed of via an authorized drug take-back program where available. If a take-back option is not accessible, the product may be discarded in household trash after being mixed with an undesirable substance, such as used coffee grounds, and placed in a sealed bag. Any unused portion of the Cimetidine injection solution must be discarded after partial administration.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cimetril found in:

A-Z Index: